ExodusPoint Capital Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

ExodusPoint Capital Management’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,854	Closed	-$54K	–	2816
2021 Q4	$54K	Buy	+10,854	New	+$65.5K	﹤0.01%	2022
2021 Q3	–	Sell	-19,954	Closed	-$171K	–	2841
2021 Q2	$171K	Buy	+19,954	New	+$170K	﹤0.01%	2031
2020 Q3	–	Sell	-3,988	Closed	-$23K	–	2365
2020 Q2	$23K	Buy	+3,988	New	+$23.1K	﹤0.01%	1706

Other funds holding FSTX

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ExodusPoint Capital Management's FSTX Position: Q1 2022 in Review

ExodusPoint Capital Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2022, closing a stake of 10,854 shares — an estimated $54K sold.

ExodusPoint Capital Management first reported a position in FSTX in Q2 2020 and held it in 3 quarters. The position peaked at $171K in Q2 2021. 40 funds tracked by Wall St. Rank hold FSTX as of Q1 2022.

ExodusPoint Capital Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 10,854 F-star Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $54K.
ExodusPoint Capital Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
ExodusPoint Capital Management's F-star Therapeutics, Inc. Common Stock position peaked at $171K in Q2 2021.
40 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.